Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Xinyun Qiu, Yan Qu, Beibei Guo, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 498-510
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 336
Chemotherapy Mediated by Biomimetic Polymeric Nanoparticles Potentiates Enhanced Tumor Immunotherapy via Amplification of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction
Yunqi Guo, Yu Fan, Zhiqiang Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 47
Closed Access | Times Cited: 81
Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief
Mengying He, Mengyao Zhang, Tao Xu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 233-250
Closed Access | Times Cited: 15
Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
Ming Xu, Jinhua Lu, Yazhen Zhong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 42
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 33
Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
Beibei Guo, Yan Qu, Yinping Sun, et al.
Bioactive Materials (2023) Vol. 25, pp. 61-72
Open Access | Times Cited: 31
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 26
Redox‐Responsive Dendrimer Nanogels Enable Ultrasound‐Enhanced Chemoimmunotherapy of Pancreatic Cancer via Endoplasmic Reticulum Stress Amplification and Macrophage Polarization
Guizhi Zhang, Mengsi Zhan, Changchang Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 23
Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy
Yi Chen, Xian Shu, Jiayi Guo, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 248-264
Closed Access | Times Cited: 11
Self‐Carrier Nanoparticles for Delivery of Paclitaxel and IDO Inhibitor to Boost Antitumor Chemo‐Immunotherapy
Zixuan Li, Qing Pei, Min Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 10
Immunological nanomaterials to combat cancer metastasis
Yuanbo Pan, Junjie Cheng, Yang Zhu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 12, pp. 6399-6444
Closed Access | Times Cited: 9
Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy
Chan Ho Kim, Kyu Eun Lee, Hyewon Ko, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 3, pp. 1088-1112
Closed Access | Times Cited: 8
Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer
Xiaohui Qian, Yang Huang, Ziqiang Ye, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15864-15877
Closed Access | Times Cited: 6
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
Lu Yuan, Shanshan Wang, Mengya Li, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access | Times Cited: 6
Core–Satellite Nanoassembly Overcomes Spatial Heterogeneity of Dendric Cell Distribution in Pancreatic Tumors for Effective Chemoimmunotherapy
Gengjia Chen, Bo Li, Tan Li, et al.
ACS Nano (2025)
Closed Access
Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer
Yao Xiao, Wenxia Yao, Mingzhen Lin, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1712-1725
Open Access | Times Cited: 30
A Cascade‐Targeted Enzyme‐Instructed Peptide Self‐Assembly Strategy for Cancer Immunotherapy through Boosting Immunogenic Cell Death
Li‐Min Xie, Yinghao Ding, Xiangyang Zhang, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 19
3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation
Fatemeh Hosseini, Masoumeh Mirzaei Chegeni, Ali Bidaki, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124697-124697
Closed Access | Times Cited: 19
Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy
Wenpan Li, Yanhao Jiang, Jianqin Lu
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122655-122655
Open Access | Times Cited: 16
Targeting the stimulator of interferon genes (STING) in breast cancer
MA Ying-rui, Bai Bu-Fan, Liu Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Biomimetic Tumor Cell Membrane‐Encapsulated Nanoparticles Combine NIR‐II Photothermal Therapy and Chemotherapy for Enhanced Immunotherapy in Triple‐Negative Breast Cancer
Wei Xiong, Ziyi Cheng, Hongwei Chen, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 5
Polymersomal Poly(I:C) Self‐Magnifies Antitumor Immunity by Inducing Immunogenic Cell Death and Systemic Immune Activation
Jingyi Wang, Beibei Guo, Zhiwei Sun, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway
Dechun Liu, Kunwei Li, Linlin Gong, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122728-122728
Closed Access | Times Cited: 13
Local Drug Delivery Techniques for Triggering Immunogenic Cell Death
En Ren, Yanfang Wang, Tingxizi Liang, et al.
Small Methods (2023) Vol. 7, Iss. 9
Closed Access | Times Cited: 12
Nanotechnology Applications in Breast Cancer Immunotherapy
Ruijie Wang, Pramod Kumar, Moataz Reda, et al.
Small (2023)
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top